Shots: The positive CHMP opinion of Forxiga (dapagliflozin) follows P-III DECLARE-TIMI 58 study evaluating the CV outcomes in 17,000+ patients with T2D across 33 countries resulted in reduction in hospitalization […]readmore
Tags : CV outcomes